Freeman and colleagues showed that reducing Panx1 protein levels with shRNA, or blockade of Panx1 channel activity using carbenoxolone or probenecid, significantly reduced the level of cell growth and cell migration of A375-P and A375-MA2 melanoma cell lines [90]. The gene discussed is PANX1; the disease is melanoma.